Real-world safety and effectiveness of roxadustat in patients with anemia of chronic kidney disease: interim results from a post-marketing surveillance study in Japan
Roxadustat safety was demonstrated in real-world clinical settings. No new safety concerns were identified.<b>Trial Registration:</b> NCT04408820.
Authors
- Naoko Wakasugi (ORCID: https://orcid.org/0000-0002-9671-7174)
- Yuichiro Ito (ORCID: https://orcid.org/0000-0002-3117-9328)
- Haruko Sugamori
- Kazuhiko Tsuruya
- Yusuke Tanaka (ORCID: https://orcid.org/0000-0002-3987-1589)
Institutions
- Astellas Pharma (United Kingdom) (GB)
- Nara Medical University Hospital (JP)
Publication Details
- Journal
- Expert Opinion on Pharmacotherapy
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1080/14656566.2025.2462181
- Citations
- 3
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.31